Holen Sie sich die Stockscreener-App
0.4734
3.51%
-0.0172
Handel nachbörslich:
.50
0.0266
+5.62%
Spruce Biosciences Inc Aktie (SPRB) Neueste Nachrichten
ARMISTICE CAPITAL, LLC Acquires New Stake in Spruce Biosciences Inc - GuruFocus.com
Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Layoff Tracker: Sensei to Cut 46% of Workforce, Close Research Site - BioSpace
Scholz Advisers Slash German Growth Forecast for Next Year - Yahoo Finance
EchoStar Q3 Earnings Lag Estimates on Lower Revenues, Stock Down 13% - Yahoo Finance
Spruce Biosciences' SWOT analysis: tildacerfont's fate hangs on Q4 trial results - Investing.com India
Spruce Biosciences Faces Nasdaq Delisting Threat: Can a Reverse Stock Split Save Its Market Presence? - TipRanks
Spruce Biosciences Reports Q3 2024 Earnings and Updates - Yahoo Finance
Should Value Investors Buy Silvercorp Metals (SVM) Stock? - Yahoo Finance
Spruce Biosciences Inc (SPRB) Quarterly 10-Q Report - Quartz
Spruce Biosciences, Inc. (SPRB) Reports Q3 Loss, Lags Revenue Estimates - MSN
US opens probe into 1.4 million Honda vehicles over engine issues - Yahoo Canada Finance
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace
Why Cambium (CMBM) International Revenue Trends Deserve Your Attention - Yahoo Finance
Spruce Biosciences Trims Losses, Eyes Critical Clinical Data in December | SPRB Stock News - StockTitan
Don't Race Out To Buy Enbridge Inc. (TSE:ENB) Just Because It's Going Ex-Dividend - Yahoo Finance
Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World
Brokerages Set Element Solutions Inc (NYSE:ESI) Target Price at $31.00 - Defense World
Vitro Diagnostics (OTCMKTS:VODG) and Tectonic Therapeutic (NASDAQ:TECX) Critical Comparison - Defense World
Analysts Set Spruce Biosciences, Inc. (NASDAQ:SPRB) Price Target at $5.00 - Defense World
Spruce Biosciences faces Nasdaq delisting notice - Investing.com India
Spruce Biosciences faces Nasdaq delisting notice By Investing.com - Investing.com South Africa
Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference - Business Wire
Global Adrenogenital Syndrome Treatment Market to Reach USD 22.08 Billion in 2033, Driven by New The - PharmiWeb.com
Congenital Adrenal Hyperplasia Clinical Trials 2024: FDA Approvals, Companies, Medication, Treatment Market, Therapies, ROA and MOA by DelveInsight | Becton, Dickinson and Company, Cook Medical, MORE - Barchart
Floyd Mayweather Jr buying $402M Black Spruce portfolio - Yahoo Finance
Congenital Adrenal Hyperplasia (CAH) Therapeutic Market 2024 - openPR
Ambev S.A. (NYSE:ABEV) Given Average Rating of “Hold” by Brokerages - Defense World
Daily Progress: Spruce Biosciences Inc (SPRB) Drop -5.56, Closing at 0.43 - The Dwinnex
The Significance of Moving Averages in Spruce Biosciences Inc Inc. (SPRB) Price Performance - The InvestChronicle
A closer look at Spruce Biosciences Inc (SPRB)’s stock price trends - US Post News
North Carolina town that produces quartz needed for tech products is devastated by Helene - Yahoo Finance
Spruce Biosciences' SWOT analysis: tildacerfont trials key for CAH stock - Investing.com
Spruce Biosciences' SWOT analysis: tildacerfont trials key for CAH stock By Investing.com - Investing.com UK
Neurocrine Biosciences's Crinecerfont is Set to Transform the Congenital Adrenal Hyperplasia Treatment Market | DelveInsight - PR Newswire
Recent Insider Activity Suggests Potential Gains for Spruce Biosciences Inc (SPRB) - Knox Daily
Spruce Biosciences Inc (SPRB) expanding its growth trajectory ahead - SETE News
Spruce Biosciences Inc [SPRB] stock for 350,951 USD was sold by Novo Holdings A/S - Knox Daily
Spruce Biosciences Inc’s results are impressive - US Post News
Financial Fitness Check: Examining Spruce Biosciences Inc (SPRB)’s Key Ratios - The Dwinnex
Checking in on Spruce Biosciences Inc (SPRB) after recent insiders movement - Knox Daily
Life Time Group Holdings Inc (LTH) gets rating Initiated from Craig Hallum - Knox Daily
Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
Potential Price Increase for Spruce Biosciences Inc (SPRB) After Recent Insider Activity - Knox Daily
SPRBSpruce Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
An Inquiry Has Been Launched Into Whether Spruce Biosciences Inc. Violated Securities Regulations And Stockholders Are Encouraged To Assist - StockTitan
Spruce Biosciences Inc (SPRB) Becoming More Attractive for Investors - Knox Daily
SPRB (Spruce Biosciences) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com
SPRB (Spruce Biosciences) Dividends per Share : $0.00 (TTM As of Jun. 2024) - GuruFocus.com
Spruce Power Holding Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.17 profit in 2Q 2023) - Yahoo Finance
Spruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - Defense World
What technical indicators reveal about SPRB stock - US Post News
Spruce Biosciences’ (SPRB) Sector Perform Rating Reaffirmed at Royal Bank of Canada - Defense World
Spruce Biosciences Inc [SPRB] Insider Activity: An Update for Investors - Knox Daily
Ratios Reveal: Breaking Down Spruce Biosciences Inc (SPRB)’s Financial Health - The Dwinnex
SPRB stock touches 52-week low at $0.42 amid market challenges - Investing.com Australia
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace
Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):